Study uses gene editing to take brakes off lab-based red blood cell production

22 octubre 2015

Turning off a single gene leads to a roughly three-to-five-fold gain in the yield of laboratory methods for producing red blood cells from stem cells, says a multi-institutional team. These findings suggest a way to cost-effectively manufacture red blood cells from stem cells; the patients who might benefit include those who cannot use blood currently available in blood banks.